Security key
55234L204
Lyra Therapeutics, Inc. - Common Stock (LYRA)
CUSIP: 55234L204
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,769,273
- Total 13F shares
- 493,700
- Share change
- +493,675
- Total reported value
- $4,423,417
- Price per share
- $8.96
- Number of holders
- 29
- Value change
- +$4,423,193
- Number of buys
- 28
Report period
Q2 2025
Institutions
29
Top holders
10
LYRA full security history
Newer quarter: Q3 2025
Lyra Therapeutics, Inc. SEC filings
Lyra Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55234L204
Recent filing periods:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
|
— |
1.1%
|
702,106
|
$84,253 | $0 | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
776%
|
12,757,562
|
$1,607,453 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
184%
|
3,018,986
|
$381,298 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
107%
|
1,765,585
|
$222,464 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
85%
|
1,390,130
|
$175,573 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
64%
|
1,058,148
|
$133,645 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
62%
|
1,016,004
|
$128,338 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
32%
|
533,200
|
$67,343 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
30%
|
488,720
|
$61,725 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
26%
|
434,226
|
$54,712 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
23%
|
370,194
|
$46,756 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
22%
|
364,478
|
$46,034 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
20%
|
332,639
|
$42,013 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
15%
|
242,546
|
$30,634 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
14%
|
233,989
|
$29,553 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
13%
|
217,567
|
$27,479 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
12%
|
193,145
|
$24,394 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
9.4%
|
154,800
|
$19,551 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
6.8%
|
111,609
|
$14,096 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
5.3%
|
87,710
|
$11,045 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
4.4%
|
71,584
|
$9,041 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
4%
|
65,619
|
$8,287 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
3.5%
|
58,213
|
$7,352 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.5%
|
58,038
|
$7,329 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.4%
|
56,277
|
$7,108 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
3.2%
|
52,736
|
$6,661 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
3%
|
50,038
|
$6,320 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
2.7%
|
43,997
|
$5,557 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
2.1%
|
35,177
|
$4,443 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2%
|
33,120
|
$4,183 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
1.8%
|
30,067
|
$3,830 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
1.8%
|
29,018
|
$3,665 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.5%
|
25,305
|
$3,196 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
1.4%
|
23,709
|
$2,994 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
23,626
|
$2,984 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
21,352
|
$2,690 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
17,541
|
$3,000 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1%
|
16,560
|
$2,092 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.93%
|
15,283
|
$1,930 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.89%
|
14,620
|
$2,000 | — | 31 Mar 2025 | |
| Abel Hall, LLC |
13F
|
Company |
0.74%
|
12,214
|
$1,543 | — | 31 Mar 2025 | |
| CIBC WORLD MARKETS CORP |
13F
|
Company |
0.65%
|
10,739
|
$1,356 | — | 31 Mar 2025 | |
| ProShare Advisors LLC |
13F
|
Company |
0.64%
|
10,477
|
$1,323 | — | 31 Mar 2025 | |
| Sassicaia Capital Advisers LLC |
13F
|
Company |
0.61%
|
10,000
|
$1,263 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.46%
|
7,486
|
$1,000 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0.41%
|
6,677
|
$1,000 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.36%
|
6,000
|
$758 | — | 31 Mar 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0.29%
|
4,741
|
$599 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.26%
|
4,272
|
$540 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.21%
|
3,507
|
$443 | — | 31 Mar 2025 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock (LYRA) as of Q2 2025
As of 30 Jun 2025,
Lyra Therapeutics, Inc. - Common Stock (LYRA) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
493,700 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE OF WISCONSIN INVESTMENT BOARD, MORGAN STANLEY, FMR LLC, and BlackRock, Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q2 2025 holders
29
Holder diff
7
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.